Pain, Postoperative
Conditions
Keywords
surgery, acute pain, post-operative pain
Brief summary
The aim of this study is to determine feasibility of a randomized controlled trial and estimates of efficacy for pain control of a scheduled pain regimen versus an as needed pain regimen for participants undergoing same day surgery procedures.
Interventions
DRUGMotrin and narcotic
See described earlier
Sponsors
Cape Fear Valley Health System
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* Any outpatient surgeries performed at Cape Fear Valley Medical Center by Dr. Van Fossen during the duration of the study, including: laparoscopic cholecystectomy, laparoscopic appendectomy, laparoscopic ventral/umbilical/incisional hernia repair, open ventral/umbilical/incisional hernia repair, laparoscopic inguinal hernia repair, open inguinal hernia repair, lumpectomy, sentinel lymph node biopsy, lymph node biopsy, mass excision skin or subcutaneous, diagnostic laparoscopy, laparoscopic lysis of adhesions, pilonidal cyst excision, hemorrhoidectomy, anal fissure/sphincterotomy, anal fistulectomy, rectal exam under anesthesia, wound debridement, and wound closure * Outpatients who are medically eligible to receive the standard post surgery medication protocol (the scheduled pain protocol used in this study). * Age 18-65
Exclusion criteria
* Participants with the following conditions will be excluded from our study: fibromyalgia, chronic pain, cancer (except for breast cancer). This is because these participants have pain at baseline and it will be difficult to discern if their pain is from surgery or their chronic condition. * Participants on chronic pain medications will also be excluded from our study because it will be difficult to tell if their pain control is related to their established regimen or the one we are implementing. * If participants who are not fluent in English, because all study materials are in English. * Participants with stage 3 Chronic Kidney Disease or higher will also be excluded from the study as they cannot take ibuprofen (according to National Kidney Foundation), which is included in our pain regimen.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Feasibility of trial | 2 weeks | To measure feasibility of the study, the following data will be collected: 1. Number of participants eligible for the study 2. Number of participants contacted about the study 3. Number of participants consented 4. Number of participants being at least 80% adherent to medication protocol 5. Number of drop-outs in the study and reason for drop out 6. Number of Adverse Events reported to study personnel. For all non-consented participants, only counts will be included (e.g., 5 participants who refused to consent), no identifying or private information will be collected. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Estimate of effect size pain control | 2 weeks | Daily diary of pain (10 point scale) |
Countries
United States
Contacts
Primary ContactKaitlyn Benson, DO
Outcome results
None listed